ConforMIS (NSDQ:CFMS) said today that it secured $50 million in debt financing from Oxford Finance LLC and that it has filed a shelf registration statement with the SEC. The debt financing and shelf registration are a part of the Bedford, Mass.-based company’s strategy to fund commercialization of its custom joint replacement implants. According to the 5-year […]
Funding Roundup
Owlstone Medical raises $11.6m for disease breathalyzer device
Owlstone Medical said today that it raised $11.6 million to help fund its disease breathalyzer device. The round was led by existing investors and follows an original investment of $7 million that spun the Cambridge, England-based company out in June last year. The funds will be used to commercially launch Owlstone’s breath biomaker R&D services, […]
Intuity Medical adds $15m to Series C for Pogo glucose meter
Intuity Medical said today that it added another $15 million to the $40 million Series C round it reported late last year, bringing the round’s total to $55 million. Sunnyvale, Calif.-based Intuity said KCK Group joined round leaders PTV Healthcare Capital and affiliates of Luther King Capital Management as new investors; existing backers Accuitive Medical Ventures, Investor […]
Neurelis closes Series B for intranasal diazepam spray
Neurelis, Inc. said today that it closed a Series B financing round, led by HBM Healthcare Investments. Other investors included LYZZ Capital, which previously led a Series A funding round for the company. Neurelis will use the funds to complete clinical trials for its intranasal diazepam spray and prepare a new drug application to submit […]
Cerêve lands $38m Series B for insomnia device
Cerêve Inc., said today that it closed a$38 million Series B found, led by global investment firm KKR. Other investors included Versant Ventures, Arboretum Ventures and Partner Ventures. The company is gearing up to launch its Cerêve Sleep System device, which is designed to reduce latency to stage 1 and stage 2 sleep for patients […]
Sofar puts another $5m into TransEnterix
TransEnterix (NYSE:TRXC) said today that Italy’s Sofar SpA agreed to buy a $5 million stake in lieu of a $10 million milestone payment as the duo amended the $100 million deal for Sofar’s Telelap ALF-X robot-assisted surgery device – now known as Senhance. In September 2015, TransEnterix bought the Senhance technology for $25 million up front and about 15.5 […]
scPharmaceuticals closes $46m Series B round
scPharmaceuticals said today that it closed a $45.6 million Series B round, co-led by OrbiMed and a subsidiary of Sun Pharmaceutical Industries. Other investors included 5AM Ventures and Lundbeckfond Ventures. The investment will be used to support the development of the operational and commercial infrastructure needed to bring Furoscix and the sc2Wear Infusor to market […]
Braeburn Pharmaceuticals files plans for $150m IPO
Braeburn Pharmaceuticals filed plans for a $150 million initial public offering last week with the Securities & Exchange Commission, leaving out any specific pricing details. The Princeton, N.J.-based company plans to list its shares on the Nasdaq market under the symbol “BBRX”. JPMorgan, Merrill Lynch and Deustche Bank are underwriters for the offering and Apple Tree […]
Stealthy NeuroVasc Technologies raises $1m
Stealthy NeuroVasc Technologies said yesterday that it raised a $1 million funding round, taking it’s total raise since last year to nearly $2.5 million. Laguna Hills, Calif.-based NeuroVasc is led by CEO Ev3 veteran Jianlu Ma, according to regulatory filings. According to the LinkedIn page of chairman Jeff Peters, the former Anulex Technologies CEO who’s also an Ev3 […]
Femasys raises $40m Series C for FemBloc permanent female contraception device
Femasys said earlier this month that it closed on a Series C round worth $40 million it plans to use on a pivotal trial of its FemBloc permanent female contraception device now that it has FDA approval for the study. Atlanta-based Femasys said the round was arranged and led by Los Angeles-based investment bank Salem Partners, with […]
Gates Foundation puts $140m into $206m round for Intarcia
Intarcia Therapeutics said today that it raised a $206m Series EE round and inked a deal with the Bill & Melinda Gates Foundation to fight HIV in emerging nations. It’s the 2nd of 3 tranches in an ongoing round for Intarcia, which is developing a drug-delivery platform called Medici, a match-sized osmotic pump designed to be placed under the […]